ARROW 2015 - Presentations

Day 1 - October 5, 2015

 

Session 1 – Neurocognitive evaluation from clinical studies to "real-world" assessment

1. NIMH Global and Domestic NeuroAIDS Programs – Dr Jeymohan Joseph - NIMH, USA

2. Neurocognitive testing – Dr. Thomas Marcotte - HNRC, San Diego, USA

3. The Romanian Pediatric Cohort 25 years Dr Mariana Mardarescu – INBI “Matei Bals”, Bucharest, Romania

4. Romanian National Neurocognitive Screening Program – Prof Adrian Streinu Cercel & Psychologist Odette Chirila - INBI “Matei Bals”, Bucharest, Romania

5. Prevalence of NCI in Netherlands – Dr. Judith Schouten, Amsterdam, Netherlands

 

Session 2 – Impact of ageing on the brain

1. Surveillance of children perinatally exposed to HIV. Interim results from The National Registry of pregnant women infected with HIV and of perinatally exposed children Dr Mariana Mardarescu - INBI “Matei Bals”, Bucharest, Romania

2. Accelerated ageing in young adults infected with HIV since childhood? Dr. Ruxandra Burlacu, Paris, France

3. Ageing and the HIV patient brain - a clinical perspective – Dr. Mike Youle, London, UK

4. HIV brain infection and Alzheimer’s disease: what is common, what is different? Prof. Bogdan Popescu - “Colentina” Hospital, Bucharest, Romania

 

Session 3 – Short interventions from local investigators on NeuroAIDS / comorbidities topic

1. Incidence and risk factors for HIV-associated cognitive-motor complex in HIV/AIDS patients: Belgrade Cohort Prof Gordana Dragovic, Belgrade, Serbia

2. Neuropsychological assessment in HIV/AIDS and its challenges in Galati County Dr Manuela Arbune, Galati, Romania

3. Assessment of everyday functioning in young adults infected with HIV since childhood Psychologist – Anca Luca - “Victor Babes” Hospital, Bucharest, Romania

 

Session 4 – Clinical Cases session - Part 1

1. Dr Anna Piddubna Kiev, Ukraine

2. Dr Alina Cibea INBI “Matei Bals”, Bucharest, Romania

3. Dr Sime Zekan Croatia

4. Dr Valeriu Gheorghita INBI “Matei Bals”, Bucharest, Romania

 

Session 5 – Clinical Cases session –Part 2

2. Dr Kristaly Franciska-Margit Tg. Mures, Romania

3. Dr Elif Tükenmez Turkey

4. Dr Irina Ianache “Victor Babes” Hospital Bucharest, Romania

 

Day 2 October 6, 2015

 

Session 6 – Clinical Cases session - Part 3

1. Dr Nina Sincu Tg. Mures, Romania

2. Dr Ioana Cociasu “Colentina” Hospital Bucharest, Romania

3. Dr Ewa Pietraszkiewicz Poland

4. Dr Luci Rotar Timisoara, Romania

 

Session 7 – HIV is not lonely in the brain

1. PML old and new – Dr Paola Cinque, Milan, Italy

2. CNS IRIS - the evil side of cART? – Dr Ruxandra Moroti & Dr Adriana Hristea Bucharest INBI “Matei Bals”, Bals, Bucharest, Romania

3. Opportunistic infections in the era of cART - still a problem in resource-limited settings – Dr Cristiana Oprea - “Victor Babes” Hospital, Bucharest, Romania

4. Challenges to HIV eradication in the brain – Prof Ronald Ellis - HNRC, USA

5. Latent Toxoplasma infection is associated with neurocognitive impairment in young adults with chronic HIV infection from Romania – Dr Luminita Ene - “Victor Babes” Hospital, Bucharest, Romania

 

Session 8 – Virology & brain pathology session

1. The cellular miRNA 29A expression as a potential marker for neurocognitive impairment in HIV infected patients – Prof Simona Ruta - IVN, Bucharest, Romania

2. CSF HIV Escape: Myth or Reality – Dr Ignacio Pérez Valero, Madrid Spain

3. HIV superinfection in IDU’s – Dr Simona Paraschiv - INBI “Matei Bals”, Romania

4. Brain vascular disease in the HAART era – Prof Cristian Achim - HNRC, San Diego, USA

 

20th European AIDS Conference

15-18 October 2025 Paris, France

EACS Guidelines updated

The EACS 12.1 and the app are available for free on

Apple Store and Google Play Store

Read more

Now available!

Special report on HIV stigma in the healthcare setting

More information

Educational Programme

Training and educating the next generation of clinicians and researchers is an EACS core activity.

Read more

EACS Resource Library

Access all scientific content of EACS core activities! (members only)

Read more

New Interim Guidance

Interim Guidance on the Use of Statin Therapy for the Primary Prevention of Cardiovascular Disease in People with HIV

Read more